Skip to main content
OpenTrials

Clinical trial condition

Perivascular Epithelioid Cell Neoplasms

Explore clinical trials studying Perivascular Epithelioid Cell Neoplasms. Study availability and eligibility vary by location and protocol.

9 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Perivascular Epithelioid Cell Neoplasms trial results

Recruiting

A Study of Pembrolizumab in People With Ultra-Rare Sarcomas

NCT07089992

Conditions
Liposarcoma, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group

NCT03967834

Conditions
Alveolar Soft Part Sarcoma, Clear Cell Sarcoma, Desmoplastic Small Round Cell Tumor, +19 more
Locations
  • Chu Besancon - Site Jean Minjoz Besançon, France
  • Institut Bergonié Bordeaux, France
  • Centre Jean Perrin Clermont-Ferrand, France
  • Centre Georges François Leclerc Dijon, France
View all 20 locations
View Trial Details
Completed

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

NCT02180867

Conditions
Alveolar Soft Part Sarcoma, Angiomatoid Fibrous Histiocytoma, Atypical Fibroxanthoma, +65 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
View all 381 locations
View Trial Details
Completed

A Phase 2 Study of Nab-sirolimus (ABI-009) in Patients With Advanced Malignant PEComa

NCT02494570

Conditions
Malignant PEComa, Neoplasms, Neoplasms by Histologic Type, +2 more
Locations
  • Stanford University Medical Center Palo Alto, California, United States
  • Sarcoma Oncology Research Center Santa Monica, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details
Active, Not Recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

NCT02834013

Conditions
Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 1007 locations
View Trial Details

Related conditions